New porphyrin platinum conjugates for the cytostatic and photodynamic tumor therapy

被引:38
作者
Brunner, H [1 ]
Schellerer, KM [1 ]
机构
[1] Univ Regensburg, Inst Anorgan Chem, D-93040 Regensburg, Germany
关键词
porphyrin platinum conjugates; cytostatic tumor therapy; photodynamic tumor therapy; MDA-MB-231 cell line;
D O I
10.1016/S0020-1693(02)01490-1
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
The combination of a porphyrin system and a platinum fragment in the same molecule should not only result in the additivity of the photodynamic activity of the porphyrin and the cytostatic activity of the platinum, but also in the enrichment of the porphyrin platinum conjugate in tumors, which platinum compounds alone do not show. New porphyrin platinum conjugates were obtained from the platinum complexes of a series of 1,2-diamines and hematoporphyrin or 13,17-bis(2-carboxyethyl)-3,8-bis [1-(ethyleneglycolmonoethylether)oxvethyl]-2,7,12,18-tetramethylporphin. The 1,2-diamines were synthesized starting from the corresponding stilbenes via 1,2-diazides. The new platinum porphyrin conjugates showed promising antitumor activity in tests with the mammary carcinoma cell line MDA-MB-231. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:39 / 48
页数:10
相关论文
共 30 条
[1]   Studies on the formulation and in vitro release of ophthalmic liposomes containing dexamethasone sodium phosphate [J].
AlMuhammad, J ;
Ozer, AY ;
Hincal, AA .
JOURNAL OF MICROENCAPSULATION, 1996, 13 (02) :123-130
[2]   A COMPARATIVE-STUDY OF THE MCMURRY REACTION UTILIZING [HTICL(THF)(APPROXIMATE-TO-0.5)](X), TICL3(DME)(1.5)-ZN(CU) AND TICL2-CENTER-DOT-LICL AS COUPLING REAGENTS [J].
BOGDANOVIC, B ;
BOLTE, A .
JOURNAL OF ORGANOMETALLIC CHEMISTRY, 1995, 502 (1-2) :109-121
[3]   Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes [J].
Boman, NL ;
Tron, VA ;
Bally, MB ;
Cullis, PR .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1996, 37 (04) :351-355
[4]   THE MECHANISM OF ASYMMETRIC HYDROGENATION - CHIRAL BIS(DIPHENYLPHOSPHINO)-ALPHA-PHENYLALKANE COMPLEXES IN CATALYTIC AND STRUCTURAL STUDIES [J].
BROWN, JM ;
MURRER, BA .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1982, (04) :489-497
[5]   Synthesis and in vitro testing of hematoporphyrin type ligands in platinum(II) complexes as potent cytostatic and phototoxic antitumor agents [J].
Brunner, H ;
Scheller, KM ;
Treittinger, B .
INORGANICA CHIMICA ACTA, 1997, 264 (1-2) :67-79
[6]   Benzoporphyrins and acetylene-substituted porphyrins as improved photosensitizers in the photodynamic tumor therapy with porphyrin platinum conjugates [J].
Brunner, H ;
Schellerer, KM .
MONATSHEFTE FUR CHEMIE, 2002, 133 (05) :679-705
[7]  
BRUNNER H, 1992, Z NATURFORSCH B, V47, P942
[8]   SYNTHESIS AND ANTITUMOR-ACTIVITY OF PLATINUM(II) COMPLEXES CONTAINING SUBSTITUTED ETHYLENEDIAMINE LIGANDS [J].
BRUNNER, H ;
HANKOFER, P ;
HOLZINGER, U ;
TREITTINGER, B ;
SCHONENBERGER, H .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1990, 25 (01) :35-44
[9]   PLATINUM(II) COMPLEXES WITH PORPHYRIN LIGANDS - SYNTHESIS AND SYNERGISMS IN THE PHOTODYNAMIC TUMOR-THERAPY [J].
BRUNNER, H ;
OBERMEIER, H ;
SZEIMIES, RM .
CHEMISCHE BERICHTE-RECUEIL, 1995, 128 (02) :173-181
[10]   SYNTHESIS AND ANTITUMOR-ACTIVITY OF NEW PORPHYRIN-PLATINUM(II) COMPLEXES WITH THE CYTOSTATIC PLATINUM FRAGMENT ATTACHED TO THE PORPHYRIN SIDE-CHAINS [J].
BRUNNER, H ;
MAITERTH, F ;
TREITTINGER, B .
CHEMISCHE BERICHTE, 1994, 127 (11) :2141-2149